Kategorie-Archiv: Research output

Collaborative research study was published in J. Hepatology

The research network around the principal investigator Tim Hendrikx (Department of Laboratory Medicine, KILM, Medical University Vienna, Vienna, Austria) published the study with the title ‚Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH.‚ The article has been been made online available by the Journal of Hepatology (IF 30.08)!) which is a TOP journal within the 5% in the field of GASTROENTEROLOGY & HEPATOLOGY.

New Publication in Biomedicine & Pharmacotherapy

Roland Hellinger contributed to a peer review publication in the Journal of Biomedicine & Pharmacotherapy.

The study with the title ‚The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma‘ studied the effects of T20K. The collaborative work was performed by researchers from the Medical University of Vienna, the Ludwig Boltzmann Institute for Cancer Research, the Karl Landsteiner University of Health Sciences, and the University of Veterinary Medicine in Vienna.

Here is a link to the online version of the article. Link

New research study on the role of the cyclic cystine-knot motif in cyclotides published

Under the contribution of the ZK-81B project PeptAIDes, a study was recently published by the ACS Chemical Biology Journal (Impact Factor 5, Q1 in Biochemistry & Mol. Medicine). The structure-function-relationship of the unique cyclic cystine-rich knot (CCK) motif in cyclotides was evaluated . The anti-proliferative bioactivity on activated immune cells of T20K is strongly dependent on the native CCK motif and cystine-knot or acyclic variants lost antiproliferative activity. The structural motif was identified as detrimental for cell penetration into mammalian cells, since only the native peptide but no truncated variants showed transport across biological membranes. Structural studies have further underlined the importance of the CCK for structure and function of anti-proliferative T20K – a drug candidate in clinical phase studies for the therapy of Multiple Sclerosis.

The study was carried out at the Institute of Pharmacology (Medical University of Vienna) and by the contribution of collaboration partner from the University of Basel, the University of Freiburg and the University of Queensland.

Hellinger, R., Muratspahić, E., Devi, S., Koehbach, J., Vasileva, M., Harvey, PJ., Craik, DJ., Gründemann, C., and Gruber, CW. Importance of the cyclic cystine knot structural motif for immunosuppressive effects of cyclotides, 2021, ACS Chem Bio, in press, doi: 10.1021/acschembio.1c00524.

PeptAIDes attending 28th Young Research Fellows Meeting, Paris (Feb 11-12, 2021)

« Ältere Einträge Letzte Einträge »